Heijman Jordi, Heusch Gerd, Dobrev Dobromir
Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.
Clin Med Insights Cardiol. 2013 Aug 11;7:127-40. doi: 10.4137/CMC.S8445. eCollection 2013.
Atrial fibrillation remains the most common arrhythmia in clinical practice. Dronedarone is an antiarrhythmic drug for the maintenance of sinus rhythm in patients with atrial fibrillation. Dronedarone is an amiodarone derivative developed to reduce the number of extracardiovascular side effects. Dronedarone has undergone extensive experimental and clinical testing during the last decade. On the aggregate, these studies have highlighted a complex set of pleiotropic actions that may contribute to dronedarone's antiarrhythmic effects. In this review, we summarize the clinical studies that have evaluated dronedarone and provide an overview of dronedarone's electrophysiological and nonelectrophysiological pleiotropic actions.
心房颤动仍然是临床实践中最常见的心律失常。决奈达隆是一种用于维持心房颤动患者窦性心律的抗心律失常药物。决奈达隆是一种胺碘酮衍生物,旨在减少心血管外副作用的数量。在过去十年中,决奈达隆已经历了广泛的实验和临床测试。总体而言,这些研究突出了一系列复杂的多效性作用,这些作用可能有助于决奈达隆的抗心律失常效果。在本综述中,我们总结了评估决奈达隆的临床研究,并对决奈达隆的电生理和非电生理多效性作用进行概述。